Pharmaceutical Accountability Foundation

The Lancet on the PAF AbbVie case: AbbVie to face potentially groundbreaking case over Humira
T

The Lancet interviewed the chair of the Pharmaceutical Accountability Foundation (Wilbert Bannenberg) about the recent verdict of the Amsterdam Court moving the case to the substantive issues. The court instructed AbbVie to answer on the PAF subpoena by 22 January 2025. PAF is very proud of our principle case on excessive profits being reported on in The Lancet of July 27th 2024. More info about our legal case can be found on our PAF website.

The article can be accessed from the Lancet’s website here, as a PDF here or read from the picture below.